Enregistrement :
8
de
11
(2023-11-22
à
2024-04-23)
Subvention, Contribution ou autre avantage financier
Investment from governments are being requested to further Entos Pharmaceuticals' research and development of genetic medicines, as well as to assist in funding an innovation centre and manufacturing facility for genetic medicines.